Transplant :: XDx presents success with AlloMap molecular expression testing to international transplant community
XDx, a molecular diagnostics company, today announced its AlloMap molecular expression test will be the subject of presentations and discussions at the 27th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) at the Hilton San Francisco.